Your browser doesn't support javascript.
loading
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens.
Jacobs, Miriam N; Colacci, Annamaria; Corvi, Raffaella; Vaccari, Monica; Aguila, M Cecilia; Corvaro, Marco; Delrue, Nathalie; Desaulniers, Daniel; Ertych, Norman; Jacobs, Abigail; Luijten, Mirjam; Madia, Federica; Nishikawa, Akiyoshi; Ogawa, Kumiko; Ohmori, Kiyomi; Paparella, Martin; Sharma, Anoop Kumar; Vasseur, Paule.
Afiliação
  • Jacobs MN; Centre for Radiation, Chemical and Environmental Hazards (CRCE), Public Health England, Chilton, UK. miriam.jacobs@phe.gov.uk.
  • Colacci A; Center for Environment, Prevention and Health, Regional Agency for Prevention, Environment and Energy Emilia Romagna Region (Arpae), Bologna, Italy.
  • Corvi R; European Commission Joint Research Centre (EC JRC), Ispra, Italy.
  • Vaccari M; Center for Environment, Prevention and Health, Regional Agency for Prevention, Environment and Energy Emilia Romagna Region (Arpae), Bologna, Italy.
  • Aguila MC; US Food and Drug Administration (FDA), Silver Spring, MD, USA.
  • Corvaro M; Corteva Agriscience, Abingdon, UK.
  • Delrue N; Organisation for Economic Cooperation and Development (OECD), Paris, France.
  • Desaulniers D; Health Canada, Ottawa, Canada.
  • Ertych N; German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment, Diedersdorfer Weg 1, 12277, Berlin, Germany.
  • Jacobs A; US Food and Drug Administration (FDA), Silver Spring, MD, USA.
  • Luijten M; National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
  • Madia F; European Commission Joint Research Centre (EC JRC), Ispra, Italy.
  • Nishikawa A; National Institute of Health Sciences, Kawasaki, Japan.
  • Ogawa K; National Institute of Health Sciences, Kawasaki, Japan.
  • Ohmori K; Kanagawa Prefectural Institute of Public Health, Chigasaki, Japan.
  • Paparella M; Division of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
  • Sharma AK; Technical University of Denmark, Lyngby, Denmark.
  • Vasseur P; CNRS University de Lorraine, Lorraine, France.
Arch Toxicol ; 94(8): 2899-2923, 2020 08.
Article em En | MEDLINE | ID: mdl-32594184
ABSTRACT
While regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests (which include mutagenicity assays). If any of the in vivo genotoxicity tests are positive, a lifetime rodent cancer bioassay may be requested, but under most chemical regulations (except plant protection, biocides, pharmaceuticals), this is rare. The decision to conduct further testing based on genotoxicity test outcomes creates a regulatory gap for the identification of non-genotoxic carcinogens (NGTxC). With the objective of addressing this gap, in 2016, the Organization of Economic Cooperation and Development (OECD) established an expert group to develop an integrated approach to the testing and assessment (IATA) of NGTxC. Through that work, a definition of NGTxC in a regulatory context was agreed. Using the adverse outcome pathway (AOP) concept, various cancer models were developed, and overarching mechanisms and modes of action were identified. After further refining and structuring with respect to the common hallmarks of cancer and knowing that NGTxC act through a large variety of specific mechanisms, with cell proliferation commonly being a unifying element, it became evident that a panel of tests covering multiple biological traits will be needed to populate the IATA. Consequently, in addition to literature and database investigation, the OECD opened a call for relevant assays in 2018 to receive suggestions. Here, we report on the definition of NGTxC, on the development of the overarching NGTxC IATA, and on the development of ranking parameters to evaluate the assays. Ultimately the intent is to select the best scoring assays for integration in an NGTxC IATA to better identify carcinogens and reduce public health hazards.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinógenos / Testes de Carcinogenicidade Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinógenos / Testes de Carcinogenicidade Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido